Search research articles
Contact Us
Filters
Showing results (31-40 of 82) with videos related to
Page
of 9
Sort By:
The Prostate
|
December 7, 2025
Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns
Kyle C McElyea, James P Purtell, Avery K Supernois, et al.
The Prostate
|
March 30, 2026
Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients
Alexandra T Skowron, Karen Childers, Courtney M Rose, et al.
The Prostate
|
March 9, 2010
Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice
Mohamed S Arredouani, Stephanie S Tseng-Rogenski, Brent K Hollenbeck, et al.
The Laryngoscope
|
February 10, 2006
Treatment of chronic posterior laryngitis with esomeprazole
Michael F Vaezi, Joel E Richter, C Richard Stasney, et al.
Plos One
|
September 15, 2023
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma
Shyam Nyati, Hans Stricker, Kenneth N Barton, et al.
The Biochemical Journal
|
October 15, 2008
Cytoprotective effects of IAPs revealed by a small molecule antagonist
Stefanie Galbán, Clara Hwang, Julie M Rumble, et al.
American Journal of Translational Research
|
April 13, 2016
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients
Clara Hwang, Seema Sethi, Lance K Heilbrun, et al.
The Prostate
|
July 5, 2022
A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis
Daniele Modonutti, Sami E Majdalany, Nicholas Corsi, et al.
JCO Oncology Practice
|
September 30, 2025
Single-Arm Investigator-Initiated Clinical Trial to Improve Germline Testing in At-Risk Patients With Prostate Cancer (IMPRINT)
Juan Javier-DesLoges, Ana Flores Pimentel, Samuel Pena, et al.
American Journal of Translational Research
|
February 21, 2012
Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment
Dejuan Kong, Elisabeth Heath, Wei Chen, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 82) with videos related to
Sort By:
Page
of 9
The Prostate
|
December 7, 2025
Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns
Kyle C McElyea, James P Purtell, Avery K Supernois, et al.
The Prostate
|
March 30, 2026
Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients
Alexandra T Skowron, Karen Childers, Courtney M Rose, et al.
The Prostate
|
March 9, 2010
Androgen ablation augments human HLA2.1-restricted T cell responses to PSA self-antigen in transgenic mice
Mohamed S Arredouani, Stephanie S Tseng-Rogenski, Brent K Hollenbeck, et al.
The Laryngoscope
|
February 10, 2006
Treatment of chronic posterior laryngitis with esomeprazole
Michael F Vaezi, Joel E Richter, C Richard Stasney, et al.
Plos One
|
September 15, 2023
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma
Shyam Nyati, Hans Stricker, Kenneth N Barton, et al.
The Biochemical Journal
|
October 15, 2008
Cytoprotective effects of IAPs revealed by a small molecule antagonist
Stefanie Galbán, Clara Hwang, Julie M Rumble, et al.
American Journal of Translational Research
|
April 13, 2016
Anti-androgenic activity of absorption-enhanced 3, 3'-diindolylmethane in prostatectomy patients
Clara Hwang, Seema Sethi, Lance K Heilbrun, et al.
The Prostate
|
July 5, 2022
A novel prognostic model predicting overall survival in patients with metastatic castration-resistant prostate cancer receiving standard chemotherapy: A multi-trial cohort analysis
Daniele Modonutti, Sami E Majdalany, Nicholas Corsi, et al.
JCO Oncology Practice
|
September 30, 2025
Single-Arm Investigator-Initiated Clinical Trial to Improve Germline Testing in At-Risk Patients With Prostate Cancer (IMPRINT)
Juan Javier-DesLoges, Ana Flores Pimentel, Samuel Pena, et al.
American Journal of Translational Research
|
February 21, 2012
Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment
Dejuan Kong, Elisabeth Heath, Wei Chen, et al.
Page
of 9